Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Koonenberry Gold Strikes High-Grade Gold at Enmore Project

  • In News
  • April 3, 2025
  • Tim Grey
Koonenberry Gold Strikes High-Grade Gold at Enmore Project

Enmore Gold Project Shows Exploration Potential

Koonenberry Gold (ASX:KNB) has returned high-grade gold intercepts from its first diamond drillhole at the Enmore Gold Project in northeast New South Wales. The results validate historical drill data and highlight the potential for a significant mineralised system.

Managing Director Dan Power described the outcome as “a truly exciting result from our first ever drillhole into the Enmore Project.”

Drill Results Confirm Significant Gold Zones

Key assay results from drillhole 25ENDD001 at the Sunnyside Prospect include:

  • 170m @ 1.75g/t Au from 77m, including:
    • 18.3m @ 9.95g/t Au from 172.9m
    • 0.3m @ 144.5g/t Au from 173.8m

The intercept aligns with previously reported visible gold zones and is associated with intense multiphase veining, sulphides, and breccia.

Power noted that the hole “was planned to target high-grade vein sets at a high angle to the main shear zone, and we have certainly demonstrated the potential for this system to carry exceptionally high gold grades.”

More Drill Results Expected in April

Koonenberry Gold is continuing its drilling campaign at the Sunnyside Prospect, with holes 2, 3, and 4 also intersecting visible gold. Assay results for these holes are expected in April.

Drilling remains ongoing, with hole 25ENDD005 currently underway. To date, 1,630.3 metres of drilling has been completed, with approximately 1,400 metres remaining.

“Samples from holes 25ENDD002, 003, and 004, which all intersected visible gold, are now at the lab and will be reported through April,” Power said.

Exploration Strategy and Geological Insights

The drill program aims to extend known mineralisation and improve geological understanding of the Enmore system.

Koonenberry Gold designed hole 25ENDD001 to confirm historical results, including OSSRC06, which previously returned 174m @ 1.83g/t Au from surface, with a high-grade section of 3m @ 8.86g/t Au from 171m.

The company reports that gold mineralisation remains open up-dip in the preferred granite host rock, along strike, and at depth.

The Enmore Gold Project, covering 302km², is located approximately 30km from Armidale and 20km south of the Hillgrove Gold-Antimony Mine. The New England Fold Belt, where Enmore is situated, hosts several large deposits, including Ravenswood (8Moz Au), Mt Morgan (7.7Moz Au, 0.36Mt Cu), and Cracow (2.5Moz Au). Despite its prospectivity, the belt remains underexplored, particularly in New South Wales.

Next Steps for Koonenberry Gold

With drilling ongoing and more assay results expected in the coming weeks, KNB is focused on expanding the mineralised system at Sunnyside. The latest results reinforce the potential for both broad intervals of gold mineralisation and high-grade zones.

“Drilling at Sunnyside is ongoing and continues to target extensions to the system, which we have demonstrated to have a 240m vertical depth extent on three sections,” Power concluded.

  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026
  •  
  •  
  •  
  •  
  • ASX:KNB
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.